Are SEM, FARM, TMRC Obtaining Fair Deals for their Shareholders?

Rhea-AI Summary

{"summary":"","positive":[],"negative":[],"faq":[]}

News Market Reaction – SEM

%

1 alert

% News Effect

On the day this news was published, SEM declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

SEM deal price: $16.50 per share FARM deal price: $1.29 per share TMRC consideration: 3,823,328 shares

3 metrics

SEM deal price $16.50 per share Cash sale of Select Medical Holdings Corporation to executive-led consortium

FARM deal price $1.29 per share Cash sale of Farmer Brothers Coffee Co. to Royal Cup Coffee and Tea

TMRC consideration 3,823,328 shares USA Rare Earth common stock offered for Texas Mineral Resources Corp.

Market Reality Check

Price: $16.25 Vol: Volume 3,654,385 is 1.89x...

high vol

$16.25 Last Close

Volume Volume 3,654,385 is 1.89x the 20-day average of 1,932,949, signaling elevated trading interest around the deal-review headline. high

Technical Shares trade near the announced cash deal price, at $16.25 versus the $16.50 offer and above the 200-day MA of $14.28, while sitting 12.66% below the 52-week high and 39.48% above the 52-week low.

Peers on Argus

Peer moves appear idiosyncratic: PACS -0.03%, AVAH -0.82%, ARDT +9.51%, NHC -2.5...

Peer moves appear idiosyncratic: PACS -0.03%, AVAH -0.82%, ARDT +9.51%, NHC -2.58%, PIII -1.67%. With SEM flat on the day and no peers in the momentum scanner, trading activity looks stock-specific to the go-private and legal-review backdrop rather than a sector-wide move.

Historical Context

5 past events · Latest: Mar 02 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 02	Take-private agreement	Positive	+8.4%	Consortium agrees to acquire SEM for $16.50 per share with premium valuation.
Feb 19	Earnings & dividend	Positive	-6.7%	Stronger 2025 results, 2026 outlook, dividend, and $1.0B buyback authorization.
Feb 17	Sponsorship renewal	Positive	+0.0%	Multi-year renewal as Philadelphia Eagles’ official physical therapy partner.
Feb 17	Earnings call notice	Neutral	+0.0%	Announcement of timing for Q4/FY2025 results and business outlook call.
Jan 21	Earnings date set	Neutral	-0.3%	Initial notice of February earnings release and conference call schedule.

Pattern Detected

Recent news has been dominated by the go-private process and solid fundamentals. The initial acquisition announcement triggered a notable price gain, while strong earnings and capital return plans saw a short-term pullback. Operational and partnership updates have generally produced muted price changes, suggesting investors are focused primarily on transaction terms and strategic alternatives.

Recent Company History

Over the last several months, Select Medical’s story has shifted from steady operations to a potential take-private. On Jan 21, 2026 and Feb 17, 2026, the company highlighted its extensive national footprint and upcoming earnings. On Feb 19, 2026, it reported higher 2025 revenue and profitability alongside dividends and a large repurchase authorization. By Mar 2, 2026, a consortium agreed to acquire SEM for $16.50 per share. Today’s law-firm investigation headline fits into this ongoing scrutiny of deal terms for shareholders.

Market Pulse Summary

This announcement highlights that a shareholder law firm is reviewing whether Select Medical’s go-pr...

Analysis

This announcement highlights that a shareholder law firm is reviewing whether Select Medical’s go-private deal at $16.50 per share delivers fair value and complies with fiduciary obligations. It fits into an ongoing sequence of merger, proxy, and governance developments. Investors may focus on disclosures in recent 8-K and Schedule 13D/A filings, the transaction’s stated premiums, and any future updates on shareholder approvals or potential changes to deal terms.

Key Terms

federal securities laws, fiduciary duties, contingent fee, securities fraud, +1 more

5 terms

federal securities laws regulatory

"investigating the following companies for potential violations of the federal securities laws"

Federal securities laws are the set of national rules that require companies and market participants to provide accurate information, prohibit deceptive practices, and ensure fair trading of stocks and bonds. Think of them as the rules of the road for financial markets: they help investors make informed choices by mandating disclosures and punishing fraud, which reduces risk and builds trust in the safety and reliability of investments.

fiduciary duties regulatory

"and/or breaches of fiduciary duties to shareholders relating to"

Fiduciary duties are the legal and ethical responsibilities that company directors, officers, or financial advisors have to put shareholders’ interests ahead of their own, acting with honesty, care, and loyalty. Think of it like a guardian managing someone’s money: choices must prioritize the owner’s benefit, avoid conflicts, and be made with prudent judgment; investors rely on these duties to ensure decisions aren’t self‑serving and to provide grounds for legal action if abused.

contingent fee financial

"We would handle any matter on a contingent fee basis, whereby you would not"

A contingent fee is a payment arrangement where a party — often a lawyer, adviser or broker — gets paid only if a specified result is achieved, such as winning a case, completing a deal or recovering funds. For investors, contingent fees matter because they shift risk from the client to the service provider, can influence the timing and size of payments, and create incentives that may affect negotiation, litigation or deal strategies, similar to hiring a contractor who gets paid only when a job is finished successfully.

securities fraud regulatory

"represents investors all over the world who have fallen victim to securities fraud"

Securities fraud is the illegal act of lying to or misleading investors about the true value or prospects of stocks, bonds or other traded financial instruments — for example by making false statements, hiding key facts, trading on secret information, or artificially moving prices. It matters to investors because it can cause sudden losses, distort fair market prices and undermine trust in markets; think of it as someone rigging a scoreboard so others place bets on the wrong team.

corporate misconduct regulatory

"victim to securities fraud and corporate misconduct. Our attorneys have been"

Corporate misconduct is when a company, its leaders, or employees break laws, violate rules, or act unethically—for example by lying about finances, bribing partners, or hiding safety problems. It matters to investors because such behavior can trigger fines, lawsuits, lost customers and damaged reputation, which often reduce future profits and the stock’s value; think of it as a team member breaking rules that drags down the whole team’s performance and trust.

AI-generated analysis. Not financial advice.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, March 6, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Select Medical Holdings Corporation (NYSE: SEM)'s sale to a consortium led by Select Medical executives and directors for $16.50 in cash per share. If you are a Select Medical shareholder, click here to learn more about your rights and options.

Farmer Brothers Coffee Co. (NASDAQ: FARM)'s sale to Royal Cup Coffee and Tea for $1.29 per share. If you are a Farmer shareholder, click here to learn more about your rights and options.

Texas Mineral Resources Corp. (OTCQB: TMRC)'s sale to USA Rare Earth, Inc. for 3,823,328 shares of USA Rare common stock. If you are a Texas Mineral shareholder, click here to learn more about your rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/are-sem-farm-tmrc-obtaining-fair-deals-for-their-shareholders-302706621.html

SOURCE Halper Sadeh LLP